The 23rd annual International Symposium on Endovascular Therapy (ISET) will take place from Jan. 16-20, 2011 in Miami Beach. At the meeting, more than 1,500 members of the endovascular community-including physicians, researchers, nurses and professionals from around the world-will discuss the field’s controversies and advances.

September 21, 2010 – A new drug-eluting stent system has received CE mark approval for diabetic patients and those experiencing a heart attack.

The PROMUS element everolimus-eluting stent system, made by Boston Scientific, can be used in patients with concomitant diabetes mellitus as well as those suffering from an acute myocardial infarction (AMI).

September 21, 2010 - Patent infringement claims by St. Jude Medical Systems against the Volcano Corporation are without merit, the company said Tuesday.

September 21, 2010 – Two companies announced that they have entered into a distribution agreement in the United States. The agreement allows Vascular Solutions to distribute Shepherd Scientific’s Angio Assist and Teirstein Edge products.

September 21, 2010 – The first patients have been enrolled in a trial testing a new treatment for refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is designed to assess the clinical efficacy of the Neovasc Reducer. The goal is to minimize angina symptoms after six months.

September 21, 2010 – Ventricular assist devices (VADs) can restore normal hemodynamics and support recovery of native cardiac function after acute myocardial infarction (AMI), according to a study published in the September 2010 issue of The Annals of Thoracic Surgery. The study looked at patients who used Abiomed’s AB5000 Ventricular Assist Device.

September 20, 2010 - Results for the first-in-human study for a robotic cath lab navigation system will be announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference. Corindus Vascular Robotics will present information on the study involving its CorPath 200 System.

September 20, 2010 – The U.S. Food and Drug Administration (FDA) has approved the Integrity coronary stent system, which is said to offer better delivery.

September 20, 2010 — McLeod Regional Medical Center in Florence, S.C., has signed a new agreement to help streamline its cardiology workflow.

September 20, 2010 - A phase 1 porcine model study demonstrated that it is possible to successfully and repeatedly deliver a mitral valve implant.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now